Skip to main content

TOWERVIEW LLC

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 1166573 NEW YORK, NY

Position in CRVS

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$1,024,100
-$53,900 QoQ
Shares Held
70,000
-50.0% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CRVS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

TOWERVIEW LLC holds $7,491,236 across 3 Biotechnology names. CRVS ranks #3 (13.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 CRVS
Corvus Pharmaceuticals, Inc.
This page
70,000 $1,024,100

All Filings in CRVS

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,024,100 70,000
2025-12-31 $1,078,000 140,000
2025-09-30 $1,252,900 170,000
2025-06-30 $680,000 170,000
2025-03-31 $405,450 127,500
2024-12-31 $414,625 77,500
2024-09-30 $620,400 117,500
2024-06-30 $728,000 400,000
2024-03-31 $680,850 382,500
2023-12-31 $768,896 436,873
2023-09-30 $500,017 342,478
2023-06-30 $469,450 205,000